A nutraceutical launch in India requires more than a general FSSAI licence. The business must correctly classify the product, use permitted ingredients within applicable limits, manufacture or import under the correct licence and product scope, follow Schedule 4 and sector-specific GMP controls, substantiate claims, use the prescribed label statements and maintain safety, testing and traceability evidence.
Product classification
Nutraceutical is a defined regulatory category, not a marketing synonym for every healthy food. A proposed product may instead be a health supplement, food for special dietary use, food for special medical purpose, prebiotic or probiotic food, novel food, proprietary food, fortified food or conventional food. Classification controls ingredients, claims, dosage form and label statements.
Regulatory framework
The Food Safety and Standards Act operates with the Health Supplements and Nutraceuticals Regulations and their amendments, product and additive rules, contaminants limits, Packaging Regulations, Labelling and Display Regulations, Advertising and Claims Regulations, licensing rules and import requirements. Use the operative Gazette text and current FSSAI directions rather than the supplied draft's outdated 2011 labelling citation.
Permitted ingredients
Confirm each vitamin, mineral, amino acid, botanical, enzyme, probiotic or other substance against the applicable schedules, purity standards, daily limits and conditions of use. An ingredient used abroad is not automatically permitted in India. A novel or unlisted ingredient may need prior approval through the applicable FSSAI pathway before commercial sale.
Licence and product scope
Manufacturers, marketers, relabellers, importers, distributors and other operators need the licence appropriate to their actual Kind of Business. The licence must cover the premises, product category and activities. Contract manufacturing does not remove the brand owner's responsibility for formula, claims, artwork, supplier approval, traceability and complaint handling.
Claims and advertising
Claims must be truthful, unambiguous and supported by adequate evidence. A food should not be presented as diagnosing, treating or curing disease. Review nutrient-content, structure/function, general well-being and disease-risk-reduction wording against the Advertising and Claims Regulations and category-specific conditions before packaging, websites, influencer content or marketplace listings go live.
Label requirements
Depending on classification, labels may need the category name, ingredient and quantity information, recommended usage, target group, warnings, contraindications, statements that the product is not for medicinal use, veg/non-veg symbol, nutrition panel, allergen information, batch/date/storage details and FSSAI particulars. Do not use a generic supplement label for every category.
GMP and FSMS
Implement hygienic design, qualified suppliers, identity testing, allergen and cross-contamination controls, calibrated dispensing, validated blending, line clearance, reconciliation, sanitation, pest control, environmental controls where needed, batch documentation and release by competent personnel. Schedule 4 and applicable category provisions form the baseline.
Testing and quality control
Set written specifications for raw materials, packaging, in-process material and finished products. Use scientifically justified tests for identity, potency, microbiology, contaminants, heavy metals, pesticides, solvents and stability as relevant. Use competent laboratories and investigate out-of-specification results before release.
Import and contract manufacturing
Importers ordinarily require Central licensing and must comply with the FSSAI food-import clearance framework. For third-party manufacturing, contracts should allocate formula ownership, approved sources, change control, testing, batch release, artwork approval, adverse-event handling, recall, audit rights and regulatory cooperation.
Launch checklist
Freeze classification; verify ingredients and limits; confirm licence and approved product scope; approve formula and specifications; validate manufacturing and shelf life; complete claims and artwork review; build traceability and complaint systems; retain substantiation; and monitor FSSAI amendments after launch.
Frequently asked questions
Can a nutraceutical claim to cure diabetes or arthritis?
Food claims must not present the product as diagnosing, treating or curing disease. Have all claim wording reviewed against the operative regulations.
Does a manufacturing licence automatically approve every formula?
No. The product, category, ingredients and scope must independently comply; some ingredients or products may require a separate approval route.
Is third-party laboratory testing mandatory for every batch?
Testing frequency and laboratory requirements depend on the product, licence conditions and risk. A documented, defensible control plan is essential.
Can tablets and capsules be sold as nutraceuticals?
Permitted dosage formats and presentation depend on the regulated category and conditions; classification cannot be based on shape alone.
Official sources and legal references
These are primary starting points used for the legal verification completed on 23 July 2026. Gazette notifications prevail over convenient compilations if they conflict.
- Food Safety and Standards Act, 2006
- FSSAI health supplements and nutraceuticals regulations
- FSSAI Advertising and Claims Regulations, 2018
- Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations, 2011
- Labelling and Display Regulations, 2020—compendium version VIII
- Packaging Regulations, 2018—compendium version V
- FSSAI hygiene requirements and Schedule 4 overview
Editorial review record
| Review level | Reviewer | Status | Date |
|---|---|---|---|
| Editorial research | TargoLegal Research and Editorial Desk | Completed | 23 July 2026 |
| Independent legal/FSSAI professional | Qualified reviewer to be assigned | Professional review pending | — |
